Zobrazeno 1 - 10
of 6 733
pro vyhledávání: '"panitumumab"'
Autor:
Sarrami N; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada., Wuest M; Department of Oncology, University of Alberta, Edmonton, Alberta T6G 1Z2, Canada., Paiva IM; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada., Leier S; Department of Oncology, University of Alberta, Edmonton, Alberta T6G 1Z2, Canada., Lavasanifar A; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada., Wuest F; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada.; Department of Oncology, University of Alberta, Edmonton, Alberta T6G 1Z2, Canada.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2024 Nov 04; Vol. 21 (11), pp. 5797-5806. Date of Electronic Publication: 2024 Oct 15.
Autor:
Latour CD; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Su IH; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Delgado M; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Pate V; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Poole C; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Edwards JK; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Stürmer T; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lund JL; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Funk MJ; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Sep; Vol. 33 (9), pp. e5885.
Autor:
Valladares-Ayerbes M; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina, 41013, Seville, Spain. mvalaye@icloud.com., Safont MJ; Consorcio Hospital General Universitario de Valencia, Universidad de Valencia, Valencia; CIBERONC, Valencia, Spain., González Flores E; Hospital Universitario Virgen de las Nieves, Granada, Spain., García-Alfonso P; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, Spain., Aranda E; Hospital Universitario Reina Sofía, Córdoba, Spain., Muñoz AL; Hospital Universitario de Burgos, Burgos, Spain., Falcó Ferrer E; Hospital Son Llàtzer, Palma, Spain., Cirera Nogueras L; Hospital Universitari Mutua de Terrassa, Terrassa, Spain., Rodríguez-Salas N; Hospital Universitario la Paz, Madrid, Spain., Aparicio J; Hospital Universitari i Politècnic La Fe, Valencia, Spain., Llanos Muñoz M; Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain., Pimentel Cáceres PP; Complejo Hospitalario Area II de Cartagena Hospital Universitario Santa Lucia, Cartagena, Spain., Castillo Trujillo OA; Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Vidal Tocino R; Complejo Asistencial Universitario de Salamanca, IBSAL, Salamanca, Spain., Salgado Fernández M; Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Salud-Salvia A; Hospital Universitario Arnau de Vilanova, Lleida, Spain., Massuti Sureda B; Hospital Universitario de Alicante, Alicante, Spain., Garcia-Carbonero R; Hospital Universitario 12 de Octubre, Imas12, UCM, Madrid, Spain., Vicente Conesa MÁ; Hospital General Universitario José Maria Morales Meseguer, Murcia, Spain., Lloansí Vila A; AMGEN S.A., Barcelona, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Oct; Vol. 26 (10), pp. 2640-2651. Date of Electronic Publication: 2024 Apr 20.
Autor:
Stone LD; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Kasten BB; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Rao S; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Gonzalez ML; Department of Pathology, University of Miami, Miami, Florida., Stevens TM; Department of Pathology, University of Kansas Medical Center, Kansas City, Kansas., Lin D; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama., Carroll W; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Greene B; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Moore LS; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Fuson A; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., James S; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Hartman YE; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., McCammon S; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Panuganti B; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Nabell LM; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama.; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Li Y; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Li M; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Bailey L; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Rosenthal EL; Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University, Nashville, Tennessee., Jeyarajan H; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Thomas CM; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama., Warram JM; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4016-4028.
Autor:
Pataky RE; Canadian Centre for Applied Research in Cancer Control, Canada; Cancer Control Research, BC Cancer, Vancouver, BC, Canada. Electronic address: rpataky@bccrc.ca., Weymann D; Canadian Centre for Applied Research in Cancer Control, Canada; Cancer Control Research, BC Cancer, Vancouver, BC, Canada., Bosdet I; Department of Pathology & Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Cancer Genetics & Genomics Laboratory, BC Cancer, Vancouver, BC, Canada., Yip S; Cancer Genetics & Genomics Laboratory, BC Cancer, Vancouver, BC, Canada; Department of Pathology, BC Cancer, Vancouver, BC, Canada., Bryan S; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada; Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada., Sadatsafavi M; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Peacock S; Canadian Centre for Applied Research in Cancer Control, Canada; Cancer Control Research, BC Cancer, Vancouver, BC, Canada; Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada., Regier DA; Canadian Centre for Applied Research in Cancer Control, Canada; Cancer Control Research, BC Cancer, Vancouver, BC, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Publikováno v:
Journal of cancer policy [J Cancer Policy] 2024 Sep; Vol. 41, pp. 100496. Date of Electronic Publication: 2024 Jul 18.
Autor:
Ballhausen A; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin. Electronic address: alexej.ballhausen@charite.de., Karthaus M; Klinikum Neuperlach/Klinikum Harlaching, Department of Hematology, Oncology, and Palliative Care, Munich., Fruehauf S; Klinik Dr. Hancken GmbH, Department of Hematology, Oncology, and Palliative Care, Stade., Graeven U; Kliniken Maria Hilf GmbH, Department of Hematology, Oncology, and Gastroenterology, Mönchengladbach., Müller L; Oncological Practice UnterEms, Leer., König AO; Department of Gastroenterology and Gastrointestinal Oncology Göttingen, Göttingen., von Weikersthal LF; Gesundheitszentrum St. Marien, Amberg., Sommerhäuser G; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Jelas I; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Alig AHS; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Kurreck A; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Stahler A; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin., Goekkurt E; Practice of Hematology and Oncology (HOPE), Hamburg., Held S; ClinAssess GmbH, Leverkusen., Kasper S; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen., Heinrich K; University Hospital, LMU Munich, Department of Medicine III, Munich; Comprehensive Cancer Center Munich, Munich., Heinemann V; University Hospital, LMU Munich, Department of Medicine III, Munich; Comprehensive Cancer Center Munich, Munich; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg., Stintzing S; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg., Trarbach T; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen; Reha-Zentrum am Meer, Bad Zwischenahn, Germany., Modest DP; Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology, and Cancer Immunology (CVK/CCM), Berlin; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg.
Publikováno v:
ESMO open [ESMO Open] 2024 Jul; Vol. 9 (7), pp. 103628. Date of Electronic Publication: 2024 Jul 13.
Autor:
Kluger N; Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Electronic address: nicolas.kluger@hus.fi., Jokela S; Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Tolkki L; Department of Dermatology, Allergology and Venereology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Publikováno v:
Annales de dermatologie et de venereologie [Ann Dermatol Venereol] 2024 Jun; Vol. 151 (2), pp. 103271. Date of Electronic Publication: 2024 Apr 27.
Autor:
Taboada Paz L; Dermatology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain., Vicente Basanta E; Dermatology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain., Monteagudo Sánchez B; Dermatology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain.
Publikováno v:
JAMA dermatology [JAMA Dermatol] 2024 Jun 01; Vol. 160 (6), pp. 667.
Autor:
Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., Geurts BS; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Zeverijn LJ; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Wit GF; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands., Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands., Kusters B; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Beerepoot LV; Department of Internal Medicine, ETZ Hospital (Elisabeth-TweeSteden Ziekenhuis), Tilburg, The Netherlands., de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., de Groot DA; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., de Groot JWB; Isala Oncology Center, Isala, Zwolle, The Netherlands., Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW School of Oncology and Development Biology, Maastricht University Center+, Maastricht, The Netherlands., Buter J; Department of Medical Oncology, Amsterdam University Medical Center, Location VuMC, Amsterdam, The Netherlands., Gelderblom HAJ; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Voest EE; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam,The Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
Publikováno v:
The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. 431-440.